內部人士可能會獲得普通股東無法享受的可觀財務利益。
擬議的交易可能包含限制更優競爭報價的條款。
鼓勵股東與本公司聯繫，討論他們的權利和選擇，且無需支付任何費用或義務。我們將以風險代理的方式處理任何事務，您無需承擔我們的法律費用或支出的自付費用。
, /PRNewswire/ -- Halper Sadeh LLC，一家投資者權益法律事務所，正在調查以下公司是否存在違反聯邦證券法和/或對股東的信託責任的潛在行為，涉及：
Kezar Life Sciences, Inc. (NASDAQ: KZR) 以每股 6.955 美元現金和一項不可轉讓的或有價值權出售給 Aurinia Pharmaceuticals Inc. 如果您是 Kezar 的股東， 請點擊這裏瞭解您的法律權利和選擇。
Equitable Holdings, Inc. (NYSE: EQH) 與 Corebridge Financial, Inc.的合併，其中每一股 Equitable 普通股將被交換為合併公司普通股的 1.55516 股。擬議交易完成後，Equitable 股東將擁有合併公司約 49% 的股份。如果您是 Equitable 的股東， 請點擊這裏瞭解您的法律權利和選擇。
Urgent.ly, Inc. (OTC MarketsOTCQB: ULYX) 以每股 5.50 美元出售給 Agero, Inc. 如果您是 Urgent.ly 的股東， 請點擊這裏瞭解您的權利和選擇 。
代表股東，Halper Sadeh LLC 可能尋求增加對價、額外披露和信息，或其他救濟和利益。
Halper Sadeh LLC 代表全球受證券欺詐和公司不當行為影響的投資者。我們的律師在實施公司改革和為受欺詐投資者追回數百萬美元方面發揮了重要作用。
律師廣告。以往的結果並不保證類似的結果。
聯繫信息：
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
世界貿易中心一號
85 層
紐約，NY 10007
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com
來源 Halper Sadeh LLP
<img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDE0Jk5ld3NJdGVtSWQ9TlkzNDE2NCZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MTQxNjEzUFJfTkVXU19VU1BSX19fX19OWTM0MTY0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDE0Jk5ld3NJdGVtSWQ9TlkzNDE2NCZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MTQxNjEzUFJfTkVXU19VU1BSX19fX19OWTM0MTY0"/>

安盛公平

CRBG

Aurinia制藥

AKRO

ULYX

Halper Sadeh LLC 正在調查 Kezar Life Sciences、Equitable Holdings 和 Urgent.ly 是否存在潛在的聯邦證券法違規和違反信託責任的行為。該公司擔心內部人士可能會在普通股東的利益受損的情況下獲得財務利益。他們鼓勵股東討論他們在擬議交易中的權利和選擇，這些交易包括 KZR 出售給 Aurinia Pharmaceuticals、EQH 與 Corebridge Financial 的合併，以及 ULYX 出售給 Agero。Halper Sadeh LLC 提供基於成功收費的法律援助

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
<div class="lb-trans">內部人士可能會獲得普通股東無法享受的可觀財務利益。
</div>The proposed transactions may contain terms that could limit superior competing offers.
<div class="lb-trans">擬議的交易可能包含限制更優競爭報價的條款。
</div>Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
<div class="lb-trans">鼓勵股東與本公司聯繫，討論他們的權利和選擇，且無需支付任何費用或義務。我們將以風險代理的方式處理任何事務，您無需承擔我們的法律費用或支出的自付費用。
</div>, /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
<div class="lb-trans">, /PRNewswire/ -- Halper Sadeh LLC，一家投資者權益法律事務所，正在調查以下公司是否存在違反聯邦證券法和/或對股東的信託責任的潛在行為，涉及：
</div>Kezar Life Sciences, Inc. (NASDAQ: KZR)'s sale to Aurinia Pharmaceuticals Inc. for $6.955 in cash per share and one non-transferable contingent value right. If you are a Kezar shareholder, click here to learn more about your legal rights and options.
<div class="lb-trans">Kezar Life Sciences, Inc. (NASDAQ: KZR) 以每股 6.955 美元現金和一項不可轉讓的或有價值權出售給 Aurinia Pharmaceuticals Inc. 如果您是 Kezar 的股東， 請點擊這裏瞭解您的法律權利和選擇。
</div>Equitable Holdings, Inc. (NYSE: EQH)'s merger with Corebridge Financial, Inc. whereby each outstanding share of Equitable common stock will be exchanged for 1.55516 shares of the combined company's common stock. Upon closing of the proposed transaction, Equitable shareholders will own approximately 49% of the combined company. If you are an Equitable shareholder, click here to learn more about your legal rights and options.
<div class="lb-trans">Equitable Holdings, Inc. (NYSE: EQH) 與 Corebridge Financial, Inc.的合併，其中每一股 Equitable 普通股將被交換為合併公司普通股的 1.55516 股。擬議交易完成後，Equitable 股東將擁有合併公司約 49% 的股份。如果您是 Equitable 的股東， 請點擊這裏瞭解您的法律權利和選擇。
</div>Urgent.ly, Inc. (OTC MarketsOTCQB: ULYX)'s sale to Agero, Inc. for $5.50 per share. If you are an Urgent.ly shareholder, click here to learn more about your rights and options .
<div class="lb-trans">Urgent.ly, Inc. (OTC MarketsOTCQB: ULYX) 以每股 5.50 美元出售給 Agero, Inc. 如果您是 Urgent.ly 的股東， 請點擊這裏瞭解您的權利和選擇 。
</div>On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits.
<div class="lb-trans">代表股東，Halper Sadeh LLC 可能尋求增加對價、額外披露和信息，或其他救濟和利益。
</div>Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
<div class="lb-trans">Halper Sadeh LLC 代表全球受證券欺詐和公司不當行為影響的投資者。我們的律師在實施公司改革和為受欺詐投資者追回數百萬美元方面發揮了重要作用。
</div>Attorney Advertising. Prior results do not guarantee a similar outcome.
<div class="lb-trans">律師廣告。以往的結果並不保證類似的結果。
</div>Contact Information:
<div class="lb-trans">聯繫信息：
</div>Halper Sadeh LLC
<div class="lb-trans">Halper Sadeh LLC
</div>Daniel Sadeh, Esq.
<div class="lb-trans">Daniel Sadeh, Esq.
</div>Zachary Halper, Esq.
<div class="lb-trans">Zachary Halper, Esq.
</div>One World Trade Center
<div class="lb-trans">世界貿易中心一號
</div>85th Floor
<div class="lb-trans">85 層
</div>New York, NY 10007
<div class="lb-trans">紐約，NY 10007
</div>(212) 763-0060
<div class="lb-trans">(212) 763-0060
</div>[email protected]
<div class="lb-trans">[email protected]
</div>[email protected]
<div class="lb-trans">[email protected]
</div>https://www.halpersadeh.com
<div class="lb-trans">https://www.halpersadeh.com
</div>SOURCE Halper Sadeh LLP
<div class="lb-trans">來源 Halper Sadeh LLP
</div><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDE0Jk5ld3NJdGVtSWQ9TlkzNDE2NCZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MTQxNjEzUFJfTkVXU19VU1BSX19fX19OWTM0MTY0" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY34164&amp;Transmission_Id=202604141613PR_NEWS_USPR_____NY34164&amp;DateId=20260414"/>

16:13 ETAre KZR, EQH, ULYX Obtaining Fair Deals for their Shareholders?

prnewswire

Urgently

Corebridge Financial

Akero Therapeutics

Kezar Life Sciences

Urgent.ly Inc.

KZR、安盛公平、Urgent.ly Inc.是否為其股東爭取到公平的交易？